Sign in
Taking people in United StatesNo phase

Exercise and Blood Vessel Function in People With Obesity

Tests whether aerobic exercise changes DNA methylation and vessel function in adults with obesity.

Key facts

Who runs it
University of Illinois Chicago
Where
Chicago, United StatesSee the site
Trial code
Registry title
DNA Methylation and Vascular Function
Status
Recruiting
People taking part
80 people, planned
Started
11 Oct 2019
Planned end
31 Aug 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Exercise training
Record updated
15 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18-50 with a BMI of 35 kg/m2 or more who are approved for bariatric surgery. It studies DNA methylation and blood vessel function.

Age
18 to 50 years
Sex
All sexes
Disease stage
Obesity with a BMI of 35 kg/m2 or more, approved for a bariatric surgery

Main reasons for not taking part

  • Current cancer, heart, kidney or liver disease
  • Gallbladder disease
  • Acute or chronic inflammatory diseases, including rheumatoid arthritis, lupus and other autoimmune or genetic diseases
  • Pregnancy
  • Current smokers or current alcohol or drug abuse

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • BMI ≥ 35 kg/m2
  • Between ages 18-50 years
  • Not pregnant
  • Approved for a bariatric surgery

Who cannot take part

  • Pregnant women will be excluded, as they will not be eligible for bariatric surgery
  • Currently abusing alcohol or drugs
  • To avoid confounding from other inflammatory conditions individuals with current cancer, heart, kidney or liver disease, gallbladder disease or acute or chronic inflammatory diseases (including rheumatoid arthritis, lupus and other autoimmune diseases and genetic diseases) will be excluded
  • Current smokers

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

Where in United States

  • University of Illinois at ChicagoChicago, United StatesContact: Abeer M Mohamed, MD, PhDTaking people

About the trial

What the trial wants to find out

The main objective is to examine DNA hypomethylation as an underlying mechanism for the increased production of inflammatory cytokines and the impaired vascular function in obese individuals and as a potential target for nonpharmacological preventive/therapeutic interventions such as aerobic exercise.

The 2 groups in the trial

  • ExercisingExisting treatment, for comparison

    12 weeks of aerobic exercise training

    Treatment: Exercise training

  • Non-exercisingNo study treatment, for comparison

    standard of care

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
DNA Methylation and Vascular Function in Obesity: Role of Exercise and Weight Loss
Plain-language title
Exercise and Blood Vessel Function in People With ObesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Criteria questions
Built from NCT03527420, who can take part
Record updated
15 September 2025